Targeting glutamine metabolism and redox state for leukemia therapy
M. A. Gregory, T. Nemkov, V. Zaberezhnyy, H. J. Park, S. Gehrke, K. C. Hansen, A. D Alessandro, J. DeGregori
This study shows that inhibiting glutaminase with CB-839 reduces glutathione and increases mitochondrial ROS in AML, leading to apoptosis, and that combining it with pro-oxidant drugs enhances cell death in AML and ALL.
bioRxiv · Apr 18, 2018Cancer Biology